The art of blocking ADP-ribosyltransferases (ARTs): nanobodies as experimental and therapeutic tools to block mammalian and toxin ARTs (Q26991574)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23627412%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

The art of blocking ADP-ribosyltransferases (ARTs): nanobodies as experimental and therapeutic tools to block mammalian and toxin ARTs (English)

2 references

PubMed

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23627412%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23627412%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23627412%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23627412%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Stephan Menzel

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23627412%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Friedrich Haag

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23627412%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

1 reference

14 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23627412%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23627412%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

280

2 references

PubMed

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23627412%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23627412%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

3543-3550

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23627412%20AND%20SRC:MED&resulttype=core&format=json

The crystal structure of diphtheria toxin

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Amino acid sequence of mammalian elongation factor 2 deduced from the cDNA sequence: homology with GTP-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Crystal structure of ADP-ribosylated ribosomal translocase from Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Therapeutic antibodies for human diseases at the dawn of the twenty-first century

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Single domain antibodies: promising experimental and therapeutic tools in infection and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Naturally occurring antibodies devoid of light chains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Engineered antibody fragments and the rise of single domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Potent enzyme inhibitors derived from dromedary heavy-chain antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Length distribution of CDRH3 in antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Properties, production, and applications of camelid single-domain antibody fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Phage display of antibody fragments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Selecting and screening recombinant antibody libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Camelid immunoglobulins and nanobody technology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Single-domain antibodies as building blocks for novel therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Formatted anti-tumor necrosis factor alpha VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Identification of single-domain, Bax-specific intrabodies that confer resistance to mammalian cells against oxidative-stress-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Single-domain llama antibodies as specific intracellular inhibitors of SpvB, the actin ADP-ribosylating toxin of Salmonella typhimurium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Llama-derived single-domain intrabodies inhibit secretion of hepatitis B virions in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Toward a unified nomenclature for mammalian ADP-ribosyltransferases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Mammalian ADP-ribosyltransferases and ADP-ribosylhydrolases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Polymorphic toxin systems: Comprehensive characterization of trafficking modes, processing, mechanisms of action, immunity and ecology using comparative genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Identification of novel components of NAD-utilizing metabolic pathways and prediction of their biochemical functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Cell-surface enzymes in control of leukocyte trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Ecto-ADP-ribose transferases: cell-surface response to local tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Extracellular NAD(+): a danger signal hindering regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Extracellular NAD+ shapes the Foxp3+ regulatory T cell compartment through the ART2-P2X7 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

ADP-ribosylation at R125 gates the P2X7 ion channel by presenting a covalent ligand to its nucleotide binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

NAD-induced T cell death: ADP-ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

NAD+ and ATP released from injured cells induce P2X7-dependent shedding of CD62L and externalization of phosphatidylserine by murine T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

NAD+ released during inflammation participates in T cell homeostasis by inducing ART2-mediated death of naive T cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

A recombinant heavy chain antibody approach blocks ART2 mediated deletion of an iNKT cell population that upon activation inhibits autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Single domain antibodies from llama effectively and specifically block T cell ecto-ADP-ribosyltransferase ART2.2 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Targeting antibodies to the cytoplasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Targeting and tracing antigens in live cells with fluorescent nanobodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

The spvB gene-product of the Salmonella enterica virulence plasmid is a mono(ADP-ribosyl)transferase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Salmonella enterica SpvB ADP-ribosylates actin at position arginine-177-characterization of the catalytic domain within the SpvB protein and a comparison to binary clostridial actin-ADP-ribosylating toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Actin is ADP-ribosylated by the Salmonella enterica virulence-associated protein SpvB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

A steric antagonism of actin polymerization by a salmonella virulence protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313

Botulinum C2 toxin ADP-ribosylates actin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12313